532
Views
1
CrossRef citations to date
0
Altmetric
Research Article

The slow dissociation rate of K-1602 contributes to the enhanced inhibitory activity of this novel alkyl–aryl-bearing fluoroketolide

, , , &
Pages 276-282 | Received 28 Jan 2015, Accepted 05 Feb 2015, Published online: 25 Mar 2015
 

Abstract

Ketolides belong to the latest generation of macrolides and are not only effective against macrolide susceptible bacterial strains but also against some macrolide resistant strains. Here we present data providing insights into the mechanism of action of K-1602, a novel alkyl–aryl-bearing fluoroketolide. According to our data, the K-1602 interacts with the ribosome as a one-step slow binding inhibitor, displaying an association rate constant equal to 0.28 × 104 M−1 s−1 and a dissociation rate constant equal to 0.0025 min−1. Both constants contribute to produce an overall inhibition constant Ki equal to 1.49 × 10−8 M, which correlates very well with the superior activity of this compound when compared with many other ketolides or fluoroketolides.

Acknowledgements

We thank Kosan Biosciences Inc. for providing the new ketolide K-1602 and Dr Daniel Wilson for critical reading of the manuscript. This work was partially supported by the Research Committee of Patras University, program “K. Karatheodori” (grant C.573 to G.P.D.), and the IKYDA program for short-term fellowship to M.K. and M.S.

Declaration of interest

The authors report no conflicts of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.